Vamsidhar Velcheti is a Hematologist Oncology specialist and an Oncologist in New York, New York. Dr. Velcheti is rated as an Elite provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration.

Gregory Riely is an Oncologist in New York, New York. Dr. Riely is rated as an Elite provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Lung Cancer, Lung Adenocarcinoma, Thymic Epithelial Tumor, Tissue Biopsy, and Liver Embolization. Dr. Riely is currently accepting new patients.

Jamie Chaft is an Oncologist in New York, New York. Dr. Chaft is rated as an Elite provider by MediFind in the treatment of Lung Adenocarcinoma. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and EGFR Positive Lung Cancer. Dr. Chaft is currently accepting new patients.

Helena Yu is an Oncologist in New York, New York. Dr. Yu is rated as an Elite provider by MediFind in the treatment of Lung Adenocarcinoma. Her top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), and Tissue Biopsy.

Matthew Hellmann is a Hematologist Oncology specialist and an Oncologist in New York, New York. Dr. Hellmann is rated as an Elite provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC).

Eugene Shostak is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Flushing, New York. Dr. Shostak is rated as an Advanced provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Tracheobronchomalacia, Acquired Tracheomalacia, Small Cell Lung Cancer (SCLC), Advanced Bronchoscopy, and Tissue Biopsy. Dr. Shostak is currently accepting new patients.

Alexander Drilon is an Oncologist in New York, New York. Dr. Drilon is rated as an Elite provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC).

Gaetano Rocco is a Thoracic Surgeon in New York, New York. Dr. Rocco is rated as an Elite provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, Advanced Bronchoscopy, and Endoscopy.

James Isbell is a Thoracic Surgeon in New York, New York. Dr. Isbell is rated as an Elite provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, Tissue Biopsy, and Thymectomy.

Charles Rudin is a Hematologist Oncology specialist and an Oncologist in New York, New York. Dr. Rudin is rated as an Elite provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), and Tissue Biopsy. Dr. Rudin is currently accepting new patients.

Paul Paik is an Oncologist in New York, New York. Dr. Paik is rated as an Elite provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Lung Cancer, Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), Tissue Biopsy, and Gamma Knife Radiosurgery.

Mark Awad is an Oncologist in New York, New York. Dr. Awad has been practicing medicine for over 18 years and is rated as an Elite provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and Thrombectomy. Dr. Awad is currently accepting new patients.

Robert Downey is an Intensive Care Medicine provider in New York, New York. Dr. Downey is rated as an Elite provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Lung Cancer, Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Endoscopy.

Mark Kris is an Oncologist in New York, New York. Dr. Kris is rated as an Elite provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Lung Adenocarcinoma, Lung Cancer, EGFR Positive Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC).

Dr. Paul C. Lee is the System Director of Thoracic Surgery at Northwell Health. Board certified in both general surgery and cardiothoracic surgery, he has over 17 years of experience as a thoracic surgeon and specializes in treating benign and malignant disorders of the lung and esophagus. He uses the most advanced minimally invasive robotic techniques, which improve surgical precision and quicken patient recovery.Dr. Lee leads the busiest thoracic surgery program in the New York City area, and is based at Long Island Jewish Medical Center. Under his direction, the program has been recognized by the Surgical Review Corporation as America's first Robotic Surgery Network of Excellence, a true testament to Dr. Lee's ongoing dedication to delivering innovative care.Dr. Lee's patients choose him not only for his results, but also for his accessibility and compassion. He understands the uncertainty that often comes with a health event or new diagnosis, as the majority of his patients are dealing with cancer. He takes the time to get to know every patient, ensuring the most individualized, compassionate care. He also offers same and next day appointments whenever possible.Collaboration is key to Dr. Lee's approach to treatment. He participates in weekly thoracic tumor boards, where specialists across many disciplines come together to discuss cases and decide on treatment plans uniquely tailored for each patient.Dr. Lee's expertise was honed at some of the finest educational institutions in the world, including Harvard University, Johns Hopkins University School of Medicine and Columbia University. Now at the top of his field, he's passionate about passing on his knowledge to other medical professionals. He's a Professor of Cardiovascular and Thoracic surgery at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He also mentors fellow surgeons at Northwell and beyond, training them in the latest robotic thoracic surgery techniques. He has published more than 100 peer-reviewed articles and has given presentations at many national and international scientific meetings in the fields of cardiopulmonary physiology, molecular cell biology and thoracic oncology.Research is also important to Dr. Lee. He has been the principal investigator of several innovative biological research trials for the treatment of lung and esophageal cancer. He's especially interested in the use of health outcome and quality metrics research in improving the delivery of thoracic surgical services to the community.Dr. Lee is a member of various prestigious medical societies including the American College of Surgeons, the American College of Chest Physicians, Society of Thoracic Surgeons, American Society of Clinical Oncology and American Association for Thoracic Surgeons. He also served as the President of the Chinese American Medical Society from 2015 to 2017. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, Thymectomy, and Endoscopy.

"Lawrence Richard Glassman, MD, is a board-certified thoracic surgeon and chief of cardiovascular and thoracic surgery at Northwell's North Shore University Hospital. He's also vice president of thoracic surgery for Northwell facilities across eastern Long Island, tasked with building out the program and expanding access to top thoracic care for more New Yorkers.Dr. Glassman began his career with a residency in general surgery at the University of Minnesota and NYU. He also completed fellowships in cardiothoracic surgery at the National Institutes of Health, Memorial Sloan-Kettering and NYU, and obtained special training in lung transplantation at the University of Pittsburgh Department of Surgery. He joined Northwell in 2003, which now has one of the busiest thoracic surgery programs in the U.S.Specializing in both cancerous and noncancerous conditions, Dr. Glassman uses advanced minimally invasive robotic techniques, which improve surgical precision and quicken patient recovery. He is renowned for taking on the most complex operations and revisional surgeries, including chest infections and traumas, and is even involved in Northwell's innovative lung transplant program. Many institutions in the region routinely seek his specialized expertise for highly intricate cases.To provide unmatched patient care, Dr. Glassman and his team believe collaboration is paramount. They hold regular multidisciplinary meetings with specialists across Northwell-including daily team rounds to discuss cardiac and thoracic patients at every Northwell hospital, as well as weekly thoracic tumor boards to develop personalized treatment plans. ""No doctor is an island. There's lots of eyes and ears checking on every single patient. Dr. Glassman is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, ALK-Positive Non-Small Cell Lung Cancer, Thymectomy, and Endoscopy.

David Zeltsman is a Thoracic Surgeon in New Hyde Park, New York. Dr. Zeltsman is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Lung Nodules, Pleuropulmonary Blastoma, Lung Cancer, Gastrostomy, and Thymectomy.

Dr. Kevin Hyman is the chief of Thoracic Surgery at Glen Cove Hospital. He also practices at Long Island Jewish Medical Center, Long Island Jewish Forest Hills and North Shore University Hospital. He has been with Northwell Health since 2007. Dr. Hyman s area of expertise is thoracic surgery, with a special emphasis on minimally invasive thoracic surgery procedures for lung and esophageal cancer, mediastinal tumors, myasthenia gravis, anti-reflux surgery and emphysema surgery. He is also skilled at an array of endobrochial and endoscopic therapies, including stenting and laser therapy.The son of two physicians his father a radiologist, his mother a pediatrician Dr. Hyman has been interested in medicine his entire life. I always loved working with my hands and trying to figure things out, so medicine interested me from early on, he says. He was originally planning on becoming a cardiac surgeon until his father passed away from cancer. He passed during my residency and that was when I realized what I wanted to do. Thoracic surgery has combined that love of working with my hands with the desire to help patients and their loved ones through cancer. Despite the heavy nature of some of the diseases Dr. Hyman treats, if you ask any one of his patients what makes him special, they ll likely say his sense of humor. I can be serious when needed, but I always try to joke around and lighten the mood, he says. Patients appreciate that I can make them laugh in a difficult time. It helps make me approachable. Behind the scenes, Dr. Hyman participates in tumor board meetings with other physicians to examine each patient s case and discuss innovative treatments and techniques. And not only is he dedicated to his patients in the present, he s determined to influence the future of cardiothoracic surgery as well he is an assistant professor of Cardiothoracic Surgery at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and a secretary at Long Island Jewish Medical Center Staff Society, an advocacy group for physicians at the medical center. I try to advocate for physicians as well as patients, he says.Dr. Hyman received his postgraduate medical training in both general and cardiothoracic surgery at New York University Medical Center, followed by a year of specialized fellowship training in advanced minimally invasive thoracic surgery at the Mount Sinai School of Medicine. He is a graduate of Cornell University College of Arts and Sciences and Cornell University Medical College. He is board certified by the American Board of Surgery and American Board of Thoracic Surgery and has been published in numerous peer-reviewed journals, including Surgery, Journal of Thoracic and Cardiovascular Surgery, American Journal of Pathology and Journal of Clinical Immunology and Immunopathology. Dr. Hyman is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Pleuropulmonary Blastoma, Gastrostomy, and Endoscopy.

Nagashree Seetharamu, MD, MBBS, is an Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology, Medical Oncology and Hospice/Palliative medicine, she specializes in cancers of the head and neck and thoracic malignancies (lung cancer, mesothelioma, thymic tumors). She maintains an active clinical practice at the Monter Cancer Center where she focuses on providing compassionate, personalized, evidence-based multidisciplinary care. Dr. Seetharamu has established her reputation at the national level through her active involvement, and leadership within influential oncology organizations that steer the direction of clinical cancer care and research across the United States, and globally. She is a full member of both the Cancer Prevention Committee and Respiratory Committee of Alliance for Clinical Trials in Oncology. This is a national, NCI-sponsored, cooperative group that develops, fund and conducts clinical trials at many academic and community oncology centers across the country. In her position on these committees, she collaborates with clinical research experts across the country to establish standards-of-care, oversees the conduct of existing clinical trials, develops innovative and impactful hypotheses, and formulate future clinical trials. Dr. Seetharamu is the institutional principal investigator on over 10 clinical trials, has co-authored over 50 publications and book chapters and is a sought after speaker at various regional, national and international events related to Head and Neck and Thoracic cancer. Dr. Seetharamu is also Associate Program Director of the Medical Oncology and Hematology Fellowship Program for the Northwell Health Cancer Institute. In this role, she provides hands-on involvement in the recruitment, education and mentorship of future generations of physicians. Dr. Seetharamu trained in internal medicine at Long Island Jewish Medical Center and in hematology/oncology at New York University Medical Center. Dr. Seetharamu is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.

Crina Vintila is a Hematologist and an Oncologist in Lake Success, New York. Dr. Vintila is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. Her top areas of expertise are Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and ALK-Positive Non-Small Cell Lung Cancer.